Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARTLNASDAQ:CELZNASDAQ:IMCCOTCMKTS:KAYS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARTLArtelo Biosciences$5.91-2.7%$6.16$4.92▼$9.30$3.32M1.0323,347 shs6,250 shsCELZCreative Medical Technology$2.47-1.2%$2.10$1.69▼$6.90$6.46M1.9855,445 shs114,395 shsIMCCIM Cannabis$2.77-6.4%$2.13$1.29▼$7.12$6.61M2.4793,344 shs118,318 shsKAYSKaya$0.04-4.3%$0.04$0.02▼$0.05$830K0.273,659 shs3,194 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARTLArtelo Biosciences0.00%-14.32%+4.68%-2.72%-19.07%CELZCreative Medical Technology0.00%+13.64%+25.00%-13.19%-32.98%IMCCIM Cannabis0.00%+12.98%+72.09%+67.23%+6.32%KAYSKaya0.00%+11.94%-1.32%0.00%-11.76%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARTLArtelo Biosciences2.1702 of 5 stars3.64.00.00.01.00.00.6CELZCreative Medical Technology0.4087 of 5 stars0.03.00.00.00.60.01.3IMCCIM Cannabis0.0568 of 5 stars0.02.00.00.01.10.00.0KAYSKayaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARTLArtelo Biosciences 3.20Buy$33.00458.75% UpsideCELZCreative Medical Technology 0.00N/AN/AN/AIMCCIM Cannabis 0.00N/AN/AN/AKAYSKaya 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest KAYS, CELZ, IMCC, and ARTL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025ARTLArtelo BiosciencesD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold6/6/2025ARTLArtelo BiosciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$36.004/28/2025ARTLArtelo BiosciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$36.00 ➝ $36.004/2/2025ARTLArtelo BiosciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$36.00 ➝ $36.00(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARTLArtelo BiosciencesN/AN/AN/AN/A$5.31 per shareN/ACELZCreative Medical Technology$10K639.73N/AN/A$3.63 per share0.68IMCCIM Cannabis$39.44M0.16N/AN/A$1.03 per share2.69KAYSKaya$10K79.59N/AN/A($0.77) per share-0.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARTLArtelo Biosciences-$9.83M-$17.94N/AN/AN/AN/A-226.99%-164.61%8/12/2025 (Estimated)CELZCreative Medical Technology-$5.49M-$3.81N/AN/AN/AN/A-85.26%-81.49%8/8/2025 (Estimated)IMCCIM Cannabis-$7.72M-$0.64N/AN/AN/A-9.10%-122.96%-11.69%8/13/2025 (Estimated)KAYSKaya-$2.08M-$0.08N/A∞N/AN/AN/A-1,044.25%8/13/2025 (Estimated)Latest KAYS, CELZ, IMCC, and ARTL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2025KAYSKayaN/A-$0.04N/A-$0.04N/A$0.01 million5/15/2025Q1 2025IMCCIM Cannabis-$0.2540$0.06+$0.3140$0.06$11.45 million$8.69 million5/13/2025Q1 2025ARTLArtelo Biosciences-$0.78-$4.32-$3.54-$0.72N/AN/A5/9/2025Q1 2025CELZCreative Medical Technology-$0.52-$0.83-$0.31-$0.83N/A$0.00 million3/31/2025Q4 2024IMCCIM Cannabis-$0.39-$0.23+$0.16-$0.23$14.48 million$9.27 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARTLArtelo BiosciencesN/AN/AN/AN/AN/ACELZCreative Medical TechnologyN/AN/AN/AN/AN/AIMCCIM CannabisN/AN/AN/AN/AN/AKAYSKayaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARTLArtelo BiosciencesN/A0.490.49CELZCreative Medical TechnologyN/A27.4327.42IMCCIM Cannabis0.100.720.59KAYSKayaN/A0.010.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARTLArtelo Biosciences0.87%CELZCreative Medical Technology1.42%IMCCIM Cannabis7.68%KAYSKayaN/AInsider OwnershipCompanyInsider OwnershipARTLArtelo Biosciences0.83%CELZCreative Medical Technology2.80%IMCCIM Cannabis5.91%KAYSKaya23.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARTLArtelo Biosciences5550,000542,000Not OptionableCELZCreative Medical Technology52.59 million2.51 millionNot OptionableIMCCIM Cannabis3402.23 million2.10 millionNot OptionableKAYSKaya422.17 million16.96 millionNot OptionableKAYS, CELZ, IMCC, and ARTL HeadlinesRecent News About These CompaniesLolong 2: Umepekto kaya kay Lolong ang alindog ni Aya? (Episode 86)May 23, 2025 | msn.comKaya Holdings Delays 10-Q FilingMay 14, 2025 | tipranks.comRicky Lee reflects on writers being 'invisible' in Philippine cinema: 'Wala sa trailers, wala sa credits'May 2, 2025 | gmanetwork.comKaya Holdings, Inc.: The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization ProgramJanuary 16, 2025 | finanznachrichten.deKaya Holdings, Inc. (OTCQB:KAYS): The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization ProgramJanuary 16, 2025 | accessnewswire.com'I feel blessed every day': Kaya's Kitchen in Belmar celebrates 20 years in businessJanuary 13, 2025 | usatoday.comStreetsboro police K-9 killed in accident, community demands answersJanuary 9, 2025 | msn.comStreetsboro K-9 dies after being hit by car: ‘Heartbreaking and horrific’January 8, 2025 | msn.comStreetsboro K-9 dies after being hit by car: 'Heartbreaking and horrific'January 8, 2025 | msn.comStreetsboro police dog struck, killed by vehicleJanuary 8, 2025 | msn.comPolice K9 dies after car hits him on Ohio roadJanuary 8, 2025 | msn.comOfficers mourn K-9 hit and killed by car while stretching his legsJanuary 8, 2025 | mysuncoast.com'Kaya didn't come back to him': Streetsboro police mourning after death of K-9 officerJanuary 8, 2025 | msn.comStreetsboro police K-9 struck, killed by vehicle Tuesday afternoonJanuary 7, 2025 | news5cleveland.comStreetsboro Police K-9 struck and killed on State Route 303January 7, 2025 | msn.com'Heartbreaking and horrific accident': Streetsboro police K-9 dies after being hit by car while on dutyJanuary 7, 2025 | wkyc.comHearts Melt at What Turns 13-Year-Old Basset Hound Into 'a Puppy Again'December 26, 2024 | msn.comKaya Holdings, Inc. and the Sacred Mushroom(TM) Psilocybin Treatment Facility Announce Inaugural Open House and New Series of Low-Dose Psilocybin SessionsDecember 23, 2024 | accesswire.comIt's Showtime: 'And The Breadwinner Is' cast, tutumpak kaya ang hula? (And The Breadwinner Is)December 19, 2024 | msn.comManic shade: It's time for Kaya Kallas to start hitting herself in the face — ZakharovaDecember 14, 2024 | eadaily.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKAYS, CELZ, IMCC, and ARTL Company DescriptionsArtelo Biosciences NASDAQ:ARTL$5.91 -0.16 (-2.70%) Closing price 03:32 PM EasternExtended Trading$5.98 +0.07 (+1.17%) As of 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.Creative Medical Technology NASDAQ:CELZ$2.47 -0.03 (-1.20%) Closing price 04:00 PM EasternExtended Trading$2.60 +0.13 (+5.26%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.IM Cannabis NASDAQ:IMCC$2.77 -0.19 (-6.42%) Closing price 04:00 PM EasternExtended Trading$2.68 -0.09 (-3.07%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Kaya OTCMKTS:KAYS$0.04 0.00 (-4.27%) As of 09:53 AM EasternKaya Holdings, Inc., a vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics and medical cannabis dispensaries primarily in the United States. It offers a range of cannabis products, including flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. The company also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, it is involved in the development of a psychedelic treatment center under The Sacred Mushroom name, that provides its guests access to psilocybin treatments, located in Portland, Oregon. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. is headquartered in Fort Lauderdale, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
